SQUADRA AVOCATS ASSISTED AMPHASTAR FRANCE PHARMACEUTICALS IN CONNECTION WITH THE REFINANCING AND CLOSING BY ITS US PARENT COMPANY AMPHASTAR PHARMACEUTICALS OF A USD 140 MILLION LOAN WITH A BANKING SYNDICATE LED BY CAPITAL ONE BANK, NATIONAL ASSOCIATION
Accueil |
Non classé @en |
SQUADRA AVOCATS ASSISTED AMPHASTAR FRANCE PHARMACEUTICALS IN CONNECTION WITH THE REFINANCING AND CLOSING BY ITS US PARENT COMPANY AMPHASTAR PHARMACEUTICALS OF A USD 140 MILLION LOAN WITH A BANKING SYNDICATE LED BY CAPITAL ONE BANK, NATIONAL ASSOCIATION
07/01/2022
Amphastar
Pharmaceuticals is a biopharmaceutical company that is engaged in the development,
manufacture and marketing of generic and proprietary injectable, intranasal and
inhalation products.
Amphastar
France Pharmaceuticals was advised by Squadra Avocats, whose Corporate-M&A
team was led by François Lan, partner, with Arnaud Bourdelat, associate.
